Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors

Gynecologic and Obstetric Investigation

Volumn 42, Issue 2, 1996, Pages 95-101

  Nakashima, Akira ^a   Kobayashi, Takao ^b   Terao, Toshihiko ^b  

^a HAMAMATSU MEDICAL CENTER   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Plasminogen activator inhibitor type 1; Plasminogen activator inhibitor type 2; Severe preeclampsia; Tissue type plasminogen activator; Urokinase type plasminogen activator

Indexed keywords

ANTIGEN; MARKER; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; PLACENTA; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY;

EID: 0029794424     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291899     Document Type: Article

References (27)

1. Hellgren M. Blomhäck M: Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the pucrperium. Gynecol Obstct Invest 1981:12:141-154.
2. Hcdner U. Ästcdt B: Studies on fibrinolytic inhibitors during pregnancy. Acta Obstct Gynecol Scand 1971:50:99-103.
3. Stirling Y. Woolf L. North WRS. Seghatchian MJ. Maeda TW: Haemostasis in normal pregnancy. Thromb Ilaemost 1984:52:176-182.
4. Takada A. Shizumc K, Ozawa T. Takahashi S. Takada Y: Characterization of various antibodies against tissue plasminogen activator using highly sensitive enzyme immunology. Thromb Res 1986:42:63-72.
5. Jänicke F, Schmitt M, Hafter R. Hollrieder A. Babic R. Ulm K, Gössner W, GraelTH: Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 1990:4:69-78.
6. Kawano T. Morimoto K. Uemura Y: Urokinase inhibitor in human placenta. Nature 1968:217:253-254.
7. van Mourik AJ. Lawrence AD. Louskutoff JD: Purification of an inhibitor of plasminogen activator synthesized by endothelial cells. J Biol Chem 1984:259:14914-14921.
8. Walker EJ. Gow L. Campbell MD, Ogston D: The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the pucrperium. Thromb Haemost 1983: 40:21-28.
9. Lecandcr I. Ästcdt B: Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. BrJ Haematol 1986:62:221-228.
10. Nilsson MI, Folding P. Lccander I. Lenner C, Ästcdt B: Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women. Br J Haematol 1986:62:215-220.
11. Shimada H. Takashima E, Soma M, Murakami M. Maeda Y, Kasakura S. Takada A. Takada Y: Source of increased plasminogen activators during pregnancy and pucrperium. Thromb Res 1989:54:91-98.
12. Aznar J, Gilabert J. Estelles A. España F: Fibrinolytic activity and protein C in preeclampsia. Thromb Haemost 1986;55:314-317.
13. Wun CT, Schleuning DW. Reich E: Isolation and characterization of urokinase from human plasma. J Biol Chem 1982;257:3276-3283.
14. Shakespeare M. Wolf P: The demonstration of urokinase antigen in whole blood. Thromb Res 1979:14:825-835.
15. Kruithof OE. Thang TC. Gudinchet A. Hauert J, Nicoloso G. Genton C, Welti H. Bachmann F: Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors. Blood 1987:69: 460-466.
16. Kruithof OE. Thang TC, Bachmann F: The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase. Thromb Haemost 1986: 55:65-69.
17. Kruithof OE, Thang TC. Ransijn A. Bachmann F: Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984:64:907-913.
18. Kruithof OE. Thang TC. Bachmann F: Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemost 1986:55:201-205.
19. Jorgensen M. Philips M. Thorsen S. Selmer J. Zeuthen J: Plasminogen activator inhibitor I is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Thromb Haemost 1987:58:872-878.
20. Ästedt B. Hagerstrand I, et al: Cellular localization in placenta of placental type plasminogen activator inhibitor. Thromb Haemost 1986:56: 201-205.
21. Ästedt B. Hägerstrand 1. Lccander I: Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb Haemost 1985:53:122-125.
22. Lecandcr I. Nilsson MI, Ästedt B: Depression of plasminogen activator activity during pregnancy by the placental inhibitor PAI-2. Fibrinolysis 1988;2:165-167.
23. Estelles A. Gilabert J. Aznar J. Loskutol TJD. Schlecf RR: Change in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989;74:1332-1338.
24. Boer K. Lccander I, ten Cate WJ. Borm JJ, Treffers EP: Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 1988:158:518-522.
25. Arias F. Andrinopoulos G. Zamora J: Whole-blood fibrinolytic activity in normal and hypertensive pregnancies and its relation to the placental concentration of urokinase inhibitor. Am J Obstet Gynecol 1979:133:624-629.
26. Kobayashi T. Terao T: Coagulation and fibrinolysis in severe prceclampsia: Placental activators and inhibitors (in Japanese). Jpn J Obstct Gynecol Neonatal Hematol 1986:10:331-341.
27. McKay DC: Chronic intravascular coagulation in normal pregnancy and prceclampsia; in Ei-senbach GM, Brod J (eds): Kidneys and Pregnancy. Contrib Nephrol. Basel, Karger. 1981. vol 25. pp 108-119.